CTRI/2017/10/010059招募中未知
Rivaroxaban versus Fondaparinux Observational Study for Thromboprophylaxis after Hip or Knee Arthroplasty
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Male or Female patients who are undergoing elective hip or knee replacement surgery
排除标准
- •Patients with active bleeding or a high risk of bleeding that contraindicated the use of rivaroxaban ;
- •Other exclusion criteria included conditions preventing bilateral venography, clinically significant liver, cardiac, renal disease, concomitant use of protease inhibitors of the human immunodeficiency virus or fibrinolytic agents, planned intermittent pneumatic compression, requirement of ongoing anticoagulant therapy, and pregnancy or breast-feeding.
研究者
相似试验
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
招募中
3 期
Efficacy and safety of rivaroxaban and subcutaneous enoxaparin after spinal surgeryIntravenous thromboembolism.Thromboembolism in the puerperiumO88.23IRCT20211109053014N1Esfahan University of Medical Sciences200
已完成
2 期
Comparing efficacy of Rivaroxaban versus Warfarin on carotid plaqueIRCT20190729044372N1Kermanshah University of Medical Sciences60
招募中
2 期
Anticoagulant therapy for cancer-associated blood clotsCancer-associated thrombosisDeep Vein ThrombosisPulmonary EmbolismVenous ThromboembolismACTRN12617000331336South East Sydney and Illawarra Area Health Service600
已完成
不适用
A randomised controlled trial with rivaroxaban and apixaban in the treatment for venous thromboembolism in cancer patientsVenous thromboembolism with cancer patientsJPRN-UMIN000026600Chiba Cancer Center100